119 related articles for article (PubMed ID: 2329562)
1. Synthesis, pharmacological effects, and conformation of 4,4-disubstituted 1,4-dihydropyridines.
Goldmann S; Born L; Kazda S; Pittel B; Schramm M
J Med Chem; 1990 May; 33(5):1413-8. PubMed ID: 2329562
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel 2-chloro-1,4-dihydropyridines by chlorination of 2-hydroxy-1,4-dihydropyridines with phosphorus oxychloride.
Cho H; Ueda M; Mizuno A; Ishihara T; Aisaka K; Noguchi T
Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2117-21. PubMed ID: 2598311
[TBL] [Abstract][Full Text] [Related]
3. [Molecular tools for the study of calcium channels: synthesis and evaluation of biological activity of new derivatives of 4-aryl-1,4-dihydropyridine groups].
Soldatov NM
Biokhimiia; 1988 Jul; 53(7):1059-68. PubMed ID: 2846077
[TBL] [Abstract][Full Text] [Related]
4. Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockers.
Rovnyak G; Andersen N; Gougoutas J; Hedberg A; Kimball SD; Malley M; Moreland S; Porubcan M; Pudzianowski A
J Med Chem; 1988 May; 31(5):936-44. PubMed ID: 2834556
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine.
Fossheim R; Svarteng K; Mostad A; Rømming C; Shefter E; Triggle DJ
J Med Chem; 1982 Feb; 25(2):126-31. PubMed ID: 7057416
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing a nitrooxy moiety at the 3-ester position.
Ogawa T; Nakazato A; Tsuchida K; Hatayama K
Chem Pharm Bull (Tokyo); 1993 Jan; 41(1):108-16. PubMed ID: 8448812
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antihypertensive activities of new 1,4-dihydropyridine containing nitroimidazolyl substituent with a nitrooxy group at the 3-ester position.
Shafiee A; Rastkary N; Jorjani M; Shafaghi B
Arch Pharm (Weinheim); 2002 Mar; 335(2-3):69-76. PubMed ID: 12043457
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of a new class of 1,4-dihydropyridines having a hydroxamic ester group in position 3 with a potential calcium antagonistic activity.
Inglesi M; Nicola M; Magnetti S
Farmaco; 1990 Dec; 45(12):1327-40. PubMed ID: 2090142
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and selective vasodilating properties of esters of 2,6-dimethyl-4-(2-difluoromethoxyphenyl)-1,4-dihydro-pyridine-3,5-di- carboxylic acid.
Dubur GJ; Veveris MM; Weinheimer G; Bisenieks EA; Makarova NR; Kimenis AA; Uldrikis JR; Lukevics EJ; Dooley D; Osswald H
Arzneimittelforschung; 1989 Oct; 39(10):1185-9. PubMed ID: 2532883
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. I.
Morita I; Tada S; Kunimoto K; Tsuda M; Kise M; Kimura K
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3898-904. PubMed ID: 3435985
[No Abstract] [Full Text] [Related]
12. Synthesis and antihypertensive activity of 1,4-dihydropyridine derivatives with a 4-(disubstituted phenyl) ring and an aminoalkyl ester group: highly potent and long-lasting calcium antagonists.
Kanno H; Yamaguchi H; Okamiya Y; Sunakawa K; Takeshita T; Naruchi T
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2049-54. PubMed ID: 1423758
[TBL] [Abstract][Full Text] [Related]
13. Imidazol-1-yl and pyridin-3-yl derivatives of 4-phenyl-1,4-dihydropyridines combining Ca2+ antagonism and thromboxane A2 synthase inhibition.
Cozzi P; Carganico G; Fusar D; Grossoni M; Menichincheri M; Pinciroli V; Tonani R; Vaghi F; Salvati P
J Med Chem; 1993 Oct; 36(20):2964-72. PubMed ID: 8411014
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. II.
Morita I; Kunimoto K; Tsuda M; Tada S; Kise M; Kimura K
Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4144-54. PubMed ID: 3435941
[No Abstract] [Full Text] [Related]
15. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structural studies and pharmacological activity of novel bicyclic compounds derived from 3,4-dihydropyridones: 4-aryl-7,7-dimethyl-2,5-dioxo-1,2,3,4,5,6,7,8-octahydroquinolines.
Novoa de Armas H; Blaton N; Peeters OM; De Ranter C; Suárez Navarro M; Verdecia Reyes Y; Ochoa Rodriguez E; Morán del Prado L; Martin León N; Quinteiro Fernández M; Seoane Prado C; Soto Cámara JL
J Pharm Belg; 1999; 54(2):48-50. PubMed ID: 10454882
[TBL] [Abstract][Full Text] [Related]
17. Syntheses and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. III.
Morita I; Haruta Y; Tomita T; Tsuda M; Kandori K; Kise M; Kimura K
Chem Pharm Bull (Tokyo); 1987 Dec; 35(12):4819-28. PubMed ID: 3451803
[No Abstract] [Full Text] [Related]
18. Dihydropyrimidine calcium channel blockers. 2. 3-substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines.
Atwal KS; Rovnyak GC; Kimball SD; Floyd DM; Moreland S; Swanson BN; Gougoutas JZ; Schwartz J; Smillie KM; Malley MF
J Med Chem; 1990 Sep; 33(9):2629-35. PubMed ID: 2391701
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Evaluation of Pharmacological Activity, and Molecular Docking of 1,4-Dihydropyridines as Calcium Antagonists.
Shaldam MA; El-Hamamsy MH; Saleh DO; El-Moselhy TF
Chem Pharm Bull (Tokyo); 2016; 64(4):297-304. PubMed ID: 26822207
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activities of optical isomers of 2-(4-diphenylmethyl-1-piperazinyl)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate (manidipine) dihydrochloride.
Kajino M; Wada Y; Nagai Y; Nagaoka A; Meguro K
Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2225-8. PubMed ID: 2598325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
